Results 241 to 250 of about 399,014 (392)

Analysis ofenvSequence Evolution in Human Immunodeficiency Virus–Infected Patients Receiving Therapy with Nonnucleoside Reverse‐Transcriptase Inhibitors [PDF]

, 2000
Carrie Dykes, Piroon Mootsikapun, A. Dexter, L. Berrios, Michael Chiulli, Richard C. Reichman, Lisa M. Demeter   +6 more
openalex   +1 more source

Structural Basis of 2-Phenylamino-4-phenoxyquinoline Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. [PDF]

Molecules, 2022
Makarasen A, Patnin S, Vijitphan P, Reukngam N, Khlaychan P, Kuno M, Intachote P, Saimanee B, Sengsai S, Techasakul S.   +9 more
europepmc   +1 more source

Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen

, 2000
José L. Casado, Kurt Hertogs, Lı́dia Ruiz, Fernando Dronda, Anja Van Cauwenberge, Albert Goday, Isabel García-Arata, Stuart Bloor, Anna Bonjoch, Jesús Blázquez, Bonaventura Clotet, Brendan Larder   +11 more
openalex   +1 more source

Association between the CYP2B6 polymorphisms and nonnucleoside reverse transcriptase inhibitors drug-induced liver injury: a systematic review and meta-analysis. [PDF]

Sci Rep
Chanhom N, Sonjan J, Inchai J, Udomsinprasert W, Chaikledkaew U, Suvichapanich S, Mahasirimongkol S, Jittikoon J.   +7 more
europepmc   +1 more source

Correction to: Drivers of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) in nine southern African countries: a modelling study. [PDF]

BMC Infect Dis, 2021
Riou J, Dupont C, Bertagnolio S, Gupta RK, Kouyos RD, Egger M, Althaus CL.   +6 more
europepmc   +1 more source

Histone deacetylase inhibitors suppress telomerase reverse transcriptase mrna expression in prostate cancer cells [PDF]

, 2001
Mitsuhiro Suenaga, Hiroshi Soda, Mikio Oka, Akihiko Yamaguchi, Katsumi Nakatomi, Ken Shiozawa, Shigeru Kawabata, Takashi Kasai, Yasuaki Yamada, Shimeru Kamihira, Chuwa Tei, Shigeru Kohno   +11 more
openalex   +1 more source

An Amazing 30-Year Journey around the DABO Family: A Medicinal Chemistry Lesson on a Versatile Class of Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. [PDF]

J Med Chem
Fabbrizi E, Chernyshov VV, Fiorentino F, Sbardella G, Ragno R, Nawrozkij M, Ivanov R, Rotili D, Mai A.   +8 more
europepmc   +1 more source

Variability in the Responses of Hepatitis B Virus D-Subgenotypes to Antiviral Therapy: Designing Pan-D-Subgenotypic Reverse Transcriptase Inhibitors. [PDF]

J Virol, 2022
Khatun M, Kumar K, Baidya A, Mondal RK, Baszczyňski O, Kalčic F, Banerjee S, Dhali GK, Das K, Chowdhury A, Janeba Z, Chakrabarti S, Datta S.   +12 more
europepmc   +1 more source

Development of a Decellularized Urinary Bladder Matrix and Heparin‐Based Cryogel for Promoting Angiogenesis

Macromolecular Bioscience, EarlyView.
A dECM‐based cryogel scaffold with sustained VEGF release is developed to promote angiogenesis in ischemic tissues. Fabricated from decellularized porcine urinary bladder matrix and heparin, the scaffold supports VEGF binding and prolonged release. The cryogel demonstrates enhanced angiogenic potential in vitro and in a murine hindlimb ischemia model ...
Dayeon Roo, Minkyu Lee, Sivashanmugam Amirthalingam, Kyung Min Ryu, Beom Seok Kim, Juan M. Melero‐Martin, Kyoung‐Ha So, Nathaniel S. Hwang   +7 more
wiley   +1 more source

Therapy with Efavirenz plus Indinavir in Patients with Extensive Prior Nucleoside Reverse‐Transcriptase Inhibitor Experience: A Randomized, Double‐Blind, Placebo‐Controlled Trial [PDF]

, 2001
David W. Haas, W. Jeffrey Fessel, Robert Delapenha, Harold A. Kessler, Daniel Seekins, Mark Kaplan, Nancy Ruíz, Lynn Ploughman, Dominic Labriola, Douglas J. Manion   +9 more
openalex   +1 more source